
Imitra 1000mg/1000mg Injection
Marketer
Trikut Humanities Bio Science Pvt Ltd
Salt Composition
Imipenem (1000mg) + Cilastatin (1000mg)
Overview Imitra 1000mg/1000mg Injection
Combiflox 1000mg/1000mg Injection, a dual-antibiotic formulation, is indicated for the treatment of serious bacterial infections. This medication targets infectious microorganisms to curtail infection spread. Administration must be overseen by a qualified medical practitioner. Strict adherence to the prescribed dosage schedule is crucial; complete the entire course, regardless of symptom improvement. Commonly reported side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions, such as redness, swelling, and pain, may occur but typically resolve spontaneously. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (e.g., skin rashes, itching, swelling, respiratory distress) require immediate emergency care. Inform your physician of all current medications and pre-existing health conditions before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs.
Primary Ingredients of Imitra 1000mg/1000mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Imitra 1000mg/1000mg Injection
Life-threatening bacterial infections
Major Benefits of Imitra 1000mg/1000mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Imitra 1000mg/1000mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Imitra 1000mg/1000mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Imitra 1000mg/1000mg Injection works:
The injectable formulation, Imitra 1000mg/1000mg, unites imipenem, an antibiotic, with cilastatin, a dehydropeptidase I inhibitor. Imipenem's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Cilastatin safeguards imipenem's efficacy by neutralizing dehydropeptidase I, an enzyme that otherwise rapidly degrades it. This synergistic action extends imipenem's therapeutic presence within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Imitra 1000mg/1000mg Injection is undetermined; therefore, physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Imitra 1000mg/1000mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Imitra 1000mg/1000mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates insignificant infant harm.
DrivingUNSAFE
The injectable medication Imitra 1000mg/1000mg can induce adverse reactions potentially impairing driving ability. Certain side effects, including hallucinations (visual, auditory, or sensory), may impact a patient's capacity to operate a vehicle.
KidneyCAUTION
The use of Imitra 1000mg/1000mg Injection requires careful consideration in individuals with impaired kidney function. Dosage modification of Imitra 1000mg/1000mg Injection might be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Imitra 1000mg/1000mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Imitra 1000mg/1000mg Injection :
Omiting a scheduled dose of Imitra 1000mg/1000mg Injection necessitates contacting your physician.
Facts to Know About Imitra 1000mg/1000mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
